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DNA polymerase g (pol g) is required to maintain the genetic integrity of the 16,569-bp human mitochondrial
genome (mtDNA). Mutation of the nuclear gene for the catalytic subunit of pol g (POLG) has been linked to a
wide range of mitochondrial diseases involving mutation, deletion, and depletion of mtDNA. We describe a het-
erozygous dominant mutation (c.1352GrA/p.G451E) in POLG2, the gene encoding the p55 accessory subunit of
pol g, that causes progressive external ophthalmoplegia with multiple mtDNA deletions and cytochrome c oxidase
(COX)–deﬁcient muscle ﬁbers. Biochemical characterization of puriﬁed, recombinant G451E-substituted p55 pro-
tein in vitro revealed incomplete stimulation of the catalytic subunit due to compromised subunit interaction.
Although G451E p55 retains a wild-type ability to bind DNA, it fails to enhance the DNA-binding strength of the
p140-p55 complex. In vivo, the disease most likely arises through haplotype insufﬁciency or heterodimerization of
the mutated and wild-type proteins, which promote mtDNA deletions by stalling the DNA replication fork. The
progressive accumulation of mtDNA deletions causes COX deﬁciency in muscle ﬁbers and results in the clinical
phenotype.
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Human mtDNA, which encodes 13 essential compo-
nents of the respiratory chain, is replicated continuously
in dividing cells and postmitotic tissues. Failure to pre-
serve the genetic integrity of the mitochondrial genome
during replication results in depletion, deletion, or mu-
tation of mtDNA, which ultimately impairs oxidative
phosphorylation and causes cellular dysfunction and dis-
ease.1 The accuracy of mtDNA replication depends on
the coordinated action of many nuclear-encoded pro-
teins and on the correct balance of nucleotides within
the mitochondrial matrix. mtDNA is replicated by DNA
polymerase g (pol g), which is composed of a 140-kDa
catalytic subunit (p140) and a 55-kDa accessory subunit
(p55).2 The catalytic subunit possesses DNA polymer-
ase, 3′–5′ exonuclease, and 5′ deoxyribose phosphate ly-
ase activities, whereas the accessory subunit is a DNA-
binding factor that confers high processivity on the
protein complex by increasing its afﬁnity to DNA.3
Mutations in the gene encoding the catalytic subunit
(POLG [GenBank accession number NM_007215])
found on chromosome 15q25 cause progressive exter-
nal ophthalmoplegia (PEO)—both dominant (PEOA1
[MIM 157640]) and recessive (PEOB [MIM 258450])—
Alpers syndrome (MIM 203700), and ataxia with pe-
ripheral neuropathy (MIM 607459).4–11 POLG muta-
tions that cause PEO are linked to the formation of
multiple mtDNA deletions in skeletal muscle. Mutation
of other nuclear genes involved in mtDNA replication
and nucleotide metabolism—including the adenine nu-
cleotide translocase (ANT1), the mtDNA helicase
Twinkle (C10orf2), thymidine kinase 2 (TK2), deoxy-
guanosine kinase (DGUOK), and thymidine phospho-
rylase (TP)—also cause human metabolic disorders ac-
companied by depletion and mutation of mtDNA.
However, the primary nuclear mutation remains unde-
ﬁned in many patients with secondary mtDNA defects.12
Given the essential role of the p55 accessory subunit
for highly processive mtDNA synthesis and enhanced
DNA binding by the pol g holoenzyme,3 POLG2 on
chromosome 17q is an obvious candidate gene for these
patients.
Here, we describe the identiﬁcation and characteri-
zation of a novel point mutation in the POLG2 gene
associated with autosomal dominant PEO. Biochemical
characterization of the mutant form of p55 reveals in-
termediate stimulation and restoration of salt tolerance,
intermediate N-ethylmaleimide (NEM) protection as-
says, no enhancement of DNA binding by the pol g
complex, and no signiﬁcant physical or functional in-
teraction of the mutant p55 with the catalytic subunit
under physiological conditions.
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Subjects and Methods
Subjects
We identiﬁed a female patient, aged 60 years, who developed
exercise intolerance and muscle pain by age 40, followed by
progressive drooping of the eyelids (ptosis), PEO, and mild
weakness of the facial and limb muscles. She had impaired
glucose tolerance, evidence of a cardiac conduction defect (left
bundle branch block and intermittent bigeminy), a fasting
blood lactate of 1.8 mM (normal !2), and a serum creatine
kinase of 664 U/liter (normal !170). Her mother had been
similarly affected but is deceased, and her two sisters are un-
affected. The patient has two asymptomatic offspring in their
30s who declined assessment and further investigation.
Mitochondrial Studies and mtDNA Molecular Genetics
Southern blot and long-range PCR of mtDNA was per-
formed using the Expand Long Template PCR System (Roche)
on DNA that was extracted from a muscle homogenate from
the index case with the use of an established protocol ampli-
fying an ∼9.9-kb fragment across the major arc.13 Cytochrome
c oxidase (COX)–succinate dehydrogenase (SDH) histochem-
istry was performed on cryostat sections of the left quadriceps
muscle biopsy. The activity of individual respiratory chain
complexes was determined in relation to citrate synthase ac-
tivity. Cryostat muscle sections were also cut and stained on
membrane slides for laser microdissection (Leica ASLMD).
Each cell was lysed, and both the total amount of mtDNA and
the amount of nondeleted mtDNAwere quantiﬁed in each ﬁber
by real-time PCR, with use of the iQ Sybr Green on the BioRad
ICycler (BioRad).14 Total mtDNA was determined in triplicate
on a single cell from a target template spanning nucleotides
3459–3569 of the mtDNAMTND1 gene. NondeletedmtDNA
was determined in triplicate on a single cell from a target
template spanning nucleotides 11145–11251 of the mtDNA
MTND4 gene. The results were expressed as the percentage
of deleted mtDNA by convention.15
Molecular Genetics
Total DNA was extracted by standard methods from either
muscle or blood from 100 patients with sporadic or familial
PEO with histochemical evidence of mitochondrial disease
(i.e., COX-deﬁcient muscle ﬁbers and/or ragged-red ﬁbers, in
greater proportions than would be expected for age-matched
healthy controls,16 and multiple deletions in skeletal muscle
demonstrated with at least two of the following methods:
Southern blot, long-range PCR, and real-time PCR).15 POLG2
was sequenced using published primer sequences incorporating
forward and reverse M13 tags, a ﬂuorescent chain-terminating
sequencing kit (Beckman Coulter Quickstart), and a Beckman
Coulter CEQ 8000 ﬂuorescent DNA analyzer. Sequences were
analyzed using Bioedit (v. 5.09) sequence alignment editor
against reference sequences. One hundred forty-four healthy
control subjects (288 control chromosomes) were screened for
the 1352GrA mutation by denaturing high-performance liq-
uid chromatography (DHPLC) of exon 8 PCR products gen-
erated from the sequencing primers (annealing temperature
57C, Transgenomic 3500HT WAVE system that used a stan-
dard solvent gradient, melt temperature 60.6C, and buffer B
59.8%).
Proteins
The catalytic subunit of human pol g was overexpressed in
baculovirus-infected Sf9 cells and was puriﬁed to homogeneity,
as described elsewhere.17,18 Several modiﬁcations were made
to the plasmid bearing the recombinant accessory subunit. The
coding sequence was transferred from pQESL-Hp55 to a pET-
based expression vector,3 and the N-terminal His6 afﬁnity tag
was removed. The new N-terminal amino acid sequence was
Met1-Asp26-Ala27-Gly28, which deletes the 25N-terminal amino
acids that compose the mitochondrial targeting sequence.3 The
amino acids Ser-His6 were added to the C-terminus to incor-
porate a new afﬁnity tag. Additionally, the QuikChange Site-
Directed Mutagenesis Kit (Stratagene) was used to change
seven rare codons (Arg36 from AGG to CGT, Pro39 from CCC
to CCG, Gly41 from GGA to GGT, Arg75 from AGA to CGT,
Arg76 from AGG to CGT, Leu79 from CTA to CTG, and Gly81
from GGA to GGT) to optimize translation in Escherichia coli.
The resulting plasmid (pET-p55CHIS) was conﬁrmed by DNA
sequencing. The G451E derivative of p55 was constructed by
site-directed mutagenesis, with the use of pET-p55CHIS as the
template and the mutagenic primers 5′-CTACTTTGGAGAAT-
GAATTAATACATCTGA-3′ and 5′-TCAGATGTATTAATT-
CATTCTCCAAAGTAG-3′ (Oligos Etc.). DNA sequencing
conﬁrmed the G451E substitution and also revealed a syn-
onymous CTGrTTG mutation at Leu codon 347 in the mu-
tant construct, which is not expected to affect the recombinant
protein. E. coli BL21(DE3) that had been transformed with a
plasmid expressing either wild-type (WT) p55 or G451E p55
was grown at 37C in 1.5 liters of Luria-Bertani media con-
taining 100 mg/ml ampicillin to an OD595 (optical density) of
1.0, and then cultures were chilled to 30C and induced for
13 h with 1 mM isopropyl thiogalactoside. Cells were har-
vested by centrifugation, were washed once with 10 mM HE-
PES (pH 7.1) and 50 mM NaCl, were frozen with liquid ni-
trogen, and were stored at 80C. Both WT p55 and G451E
p55 were puriﬁed to homogeneity from frozen cell pellets as
described elsewhere,3 except that the Triton X-100 in the third
wash buffer for Ni-NTA agarose chromatography was re-
placed with 0.01% NP-40. Whereas the N-terminal His6-
tagged p55 protein eluted from a MonoS column at ∼0.54 M
NaCl,3 both the WT and G451E C-terminal His6-tagged de-
rivatives eluted from MonoS at 0.34 M NaCl. Codon opti-
mization enhanced protein production 4- to 10-fold relative
to the original construct, which permitted puriﬁcation of up
to 1.5 mg p55 (fraction IV) from each liter of culture media.
For the current study, both forms of p55 (fraction IV) were
transferred into a buffer containing 10 mM HEPES (pH 7.4),
0.15 M NaCl, 3 mM EDTA, and 0.005% surfactant P20 (pol-
ysorbate 20), by passage through a 5-ml HiTrap desalting col-
umn (Amersham Biosciences), before being frozen with liquid
nitrogen and stored at 80C.
Enzymatic Assays
DNA polymerase activity was determined as described else-
where3 and used poly(rA)-oligo(dT)12–18 (Amersham Biosci-
ences) as the substrate. The two-subunit form of pol g was
1028 The American Journal of Human Genetics Volume 78 June 2006 www.ajhg.org
Figure 1 Skeletal muscle histochemistry and mtDNA analysis.
A, Dual COX-SDH histochemistry (see the “Subjects and Methods”
section) showing a mosaic distribution of COX-deﬁcient muscle ﬁbers
(blue) among ﬁbers with normal COX activity (brown). B, Long-range
PCR of skeletal muscle mtDNA (extracted from a tissue homogenate).
Lane 1, 1-kb ladder; lane 2, young control muscle; lane 3, age-matched
control muscle; lane 4, patient muscle showing multiple mtDNA de-
letions. C, Real-time PCR analysis of COX-negative muscle ﬁbers. The
majority of ﬁbers contain high-percentage levels of mtDNA deletions
that remove the ND4 region (see the “Subjects andMethods” section).
reconstituted as described elsewhere,3 and reactions contained
the indicated quantities of NaCl and/or the inhibitor NEM.
The processivity of pol g was determined by monitoring the
extension of a 5′-end–labeled oligonucleotide primer hybrid-
ized to M13mp18 DNA, as described elsewhere.19 Reaction
products were resolved by denaturing polyacrylamide gel elec-
trophoresis and alkaline agarose gel electrophoresis3 and were
visualized with a Typhoon 9400 PhosphorImager (Molecular
Dynamics) and NIH Image 1.63 software.
Analytical DNA-Cellulose Chromatography
A 1-ml column of single-stranded DNA cellulose (Sigma)
was equilibrated at 4C in 0.025 M Tris-Cl (pH 7.5), 10%
glycerol, 1 mM 2-mercaptoethanol, and 0.1 mMEDTA (buffer
A) also containing 0.025 M NaCl. Samples of puriﬁed recom-
binant p140, WT p55, and G451E p55 were adjusted by di-
lution to the ionic strength of this buffer and were applied to
the column, which was washed with 9.5 ml of equilibration
buffer and was developed with a 15-ml linear gradient of NaCl
(0.025–0.6 M) in buffer A. Samples of each gradient fraction
were analyzed by SDS-PAGE on 4%–20% gradient gels (In-
vitrogen), with the use of a Tris-glycine buffer system, and
proteins were stained with Coomassie Brilliant Blue.
Immunoprecipitation Assay
Rabbit polyclonal antibodies (DPg) against recombinant pol
g17 were immobilized on Protein G Sepharose beads (Amer-
sham Biosciences), and the beads were then equilibrated in
phosphate buffered saline NP-40 (PBSN)–BSA buffer consist-
ing of 0.05 M KPO4 (pH 7.5), 0.15 M NaCl, 0.1% NP-40,
and 0.1 mg/ml BSA. Prepared DPg Protein G Sepharose beads
(10 ml) were mixed as indicated with puriﬁed WT pol g (3 mg),
A467T mutant pol g (3 mg), and/or the p55 accessory subunit
(3 mg) in a 1.5-ml polypropylene microfuge tube and were
brought to a ﬁnal volume of 0.4 ml with PBSN-BSA. Tubes
were rotated end over end for 45 min at 4C, and beads were
collected by microcentrifugation at 5,000 rpm for 2 min at
4C. The supernatant was removed and beads were washed
twice with PBSN-BSA and once with PBSN lacking BSA. Beads
were resuspended in 25 ml 2# lithium dodecyl sulfate (LDS)
loading buffer (4# LDS loading buffer from Invitrogen, made
2# with PBSN lacking BSA), and the samples were heated for
10 min at 70C before analysis on 4%–12% NuPage Bis-Tris
polyacrylamide gels (Invitrogen). After electrophoresis, the
proteins were electrotransferred to an Immobilon-P PVDF (po-
lyvinylidene ﬂuoride) membrane (Millipore). The membrane
was then washed in TNT (50 mM Tris-HCl [pH 7.5], 0.5 M
NaCl, and 0.1% Triton X-100) for 15 min and was blocked
with 5% dried milk in TN (50 mM Tris-HCl [pH 7.5] and
0.5 M NaCl) at room temperature. The blot was incubated
with 0.2 mg/ml anti-Penta-His monoclonal antibody (Qiagen)
in TN containing 0.1 mg/ml BSA for 2 h, was washed three
times with TN for 10 min, and was incubated in a 1/3,000
dilution of goat anti-mouse alkaline phosphatase–conjugated
secondary antibody (Bio-Rad) for 1 h. After three 10-min
washes in TNT and three 10-min washes in TN, bands were
visualized with Western Blue reagent (Promega).
Other Methods
Protein concentration was determined in relation to a BSA
standard, as described by Bradford.20
Results
Mitochondrial Biochemistry and mtDNA Analysis
Skeletal muscle histochemistry on the index case re-
vealed a mosaic COX defect with 6% COX-negative
ﬁbers (ﬁg. 1A). Biochemical analysis of a skeletal muscle
homogenate revealed normal respiratory chain complex
activity. Southern blot analysis and long-range PCR of
skeletal muscle mtDNA revealed multiple mtDNA de-
letions (ﬁg. 1B). Real-time PCR of single muscle ﬁbers
detected high-percentage levels of deleted mtDNA in the
majority of COX-defective muscle ﬁbers, which is typical
of a multiple mtDNA deletion disorder (ﬁg. 1C).15
Identiﬁcation of a Heterozygous Mutation in POLG2
Sequence analysis revealed no mutations in ANT1,
C10orf2, or POLG. Given the critical role of the p55
subunit in pol g function in vitro, we sequenced the eight
coding exons and adjacent intronic regions of POLG2
in this patient, as well as in 100 other patients with PEO
and multiple mtDNA deletions in skeletal muscle and
who were known to not have mutations in ANT1,
C10orf2, or POLG. A single heterozygous transition
(1352GrA) was identiﬁed in the patient described
above, whereas her two unaffected sisters did not harbor
the mutation (ﬁg. 2A and 2B). The mutation was not
detected in 288 control chromosomes from the same
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Figure 2 A novel mutation in POLG2. A, Pedigree of the pro-
band (II-2, arrow) and her unaffected siblings. B, Sequence traces
showing a heterozygous base substitution in the proband, which is
absent in her unaffected sisters. C, DHPLC traces for an exon 8 am-
plicon from the proband (upper) and control individual (lower). D,
Amino acid conservation across species in exon 8 of POLG2, with
codon 451 identiﬁed in red.
Figure 3 Effects of WT p55 and G451E p55 on pol g activity.
DNA polymerase activity was measured on poly(rA)-oligo(dT), as de-
scribed in the “Subjects and Methods” section. Reactions contained
12 ng (88 fmol) p140, either alone (squares) or with 9.6 ng (178 fmol)
of WT p55 (triangles) or G451E p55 (circles), and the indicated
amounts of NaCl. Values are the averages of two independent
measurements.
geographic region by DHPLC analysis (ﬁg. 2C). The
1352GrA mutation is predicted to alter a highly con-
served glycine to glutamate at codon 451 (G451E) (ﬁg.
2D).
Reduced Stimulation of p140 by G451E p55
Given the central role of p55 in mtDNA replication,
we tested whether the phenotypic changes caused by the
G451E substitution would also result in measurable bio-
chemical defects. For comparison of the biochemical
properties of WT p55 and G451E p55, both forms of
the protein lacking the mitochondrial targeting sequence
were overproduced in E. coli and were puriﬁed to ap-
parent homogeneity, as described in the “Subjects and
Methods” section. The catalytic activities of isolated
p140 on natural DNA substrates are inhibited by phys-
iological concentrations of salt, and association of p140
with WT p55 both stimulates polymerase activity and
signiﬁcantly raises the ionic strength for optimal pol g
activity.3,17 The ability of G451E p55 to affect the poly-
merase activity of p140 on poly(rA)-oligo(dT) was as-
sessed at a variety of salt concentrations (ﬁg. 3).Whereas
WT p55 stimulated p140 activity almost threefold and
raised the salt optimum from ∼75 mM to ∼150 mM
NaCl (compare squares and triangles in ﬁg. 3), the
G451E form of p55 enhanced polymerase activity only
about twofold, with merely a 25-mM increase in the salt
optimum (circles in ﬁg. 3). Neither protein was able to
stimulate p140 in the absence of supplemental salt. Be-
cause stimulation and restoration of salt tolerance by
p55 occur through a mechanism of enhanced DNAbind-
ing by the p140-p55 complex,3 we hypothesized that the
incomplete stimulation and limited restoration of salt
tolerance exhibited by G451E p55 were caused by al-
tered DNA binding by G451E p55 and/or an impaired
interaction with the p140 catalytic subunit.
DNA Binding by G451E p55
The WT accessory subunit binds double-stranded
DNA and folded single-stranded DNA.3,21 Single-
stranded DNA–cellulose chromatography was used to
measure the intrinsic strength with which WT p55 and
G451E p55 bind to DNA (ﬁg. 4A). As expected, WT
p55 dissociated from the resin at 0.22 M NaCl (dashed
line in ﬁg. 4A). In a separate test, G451E p55 also eluted
at 0.22 M NaCl, demonstrating that the mutant protein
retains the ability to bind DNA with the same strength
as WT p55 (solid line in ﬁg. 4A). Elution of isolated
p140 at ∼0.20 M NaCl is also shown (dotted line in ﬁg.
4A). Since the DNA-binding properties and the chro-
matographic behavior during puriﬁcation of G451E p55
were indistinguishable from that ofWT p55, the analysis
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Figure 4 Analysis of pol g subunits by analytical single-stranded
DNA–cellulose chromatography. Puriﬁed recombinant p140,WT p55,
and G451E p55 were resolved by single-stranded DNA–cellulose chro-
matography, as described in the “Subjects and Methods” section. Elu-
tion of proteins from the column was monitored by absorbance at 280
nm. A, WT p55 (dashed line), G451E p55 (solid line), or p140 (dotted
line) were applied separately and eluted with an NaCl gradient. B,
The p140 catalytic subunit (29 mg) was mixed with 31 mg WT p55
(dashed line) or 27 mg G451E p55 (solid line) and was eluted as before.
Samples of the indicated fractions of the p140-WT p55 proﬁle (C) and
the p140-G451E p55 proﬁle (D) were resolved by SDS-PAGE andwere
stained with Coomassie Brilliant Blue, as described in the “Subjects
and Methods” section. Arrows indicate the individual migration po-
sitions of p140 and p55 (C and D).
Figure 5 G451E p55 only partially protects p140 against in-
activation by NEM. DNA polymerase activity was measured as de-
scribed in the “Subjects and Methods” section, except that 2-mercap-
toethanol was excluded. Reactions contained 75 mM NaCl, 8.0 ng
(58 fmol) p140—either alone (squares) or in the presence of 6.3 ng
(116 fmol) WT p55 (triangles) or G451E p55 (circles)—and the in-
dicated amounts of NEM. Values are the average of at least two in-
dependent measurements.
was extended to search for potential defects in subunit
interaction. When puriﬁed p140 and WT p55 were
mixed brieﬂy and were applied to the DNA-cellulose
column (ﬁg. 4B), more than half of the protein in the
mixture bound the resin more tightly and eluted at∼0.32
M NaCl (dashed line in ﬁg. 4B) in fractions 19 and 20
(ﬁg. 4C). The enhanced DNA-binding properties of this
salt-stable pol g complex has been documented else-
where.3 In contrast, G451E p55 and p140 failed to form
a more tightly binding complex (solid line in ﬁg. 4B).
Instead, each protein in the mixture chromatographed
independently, with peak elution of both proteins at
0.22 M NaCl in fractions 17 and 18 (ﬁg. 4D). This
apparent inability of the G451E p55 and p140 subunits
to assemble into a pol g holoenzyme complex prompted
additional experiments to evaluate the functional and
physical interactions of the subunits.
G451E p55 Exhibits Reduced Protection of p140
against Inactivation by NEM
NEM inhibits certain enzymes, including human pol
g, through covalent modiﬁcation of solvent-accessible
cysteine residues. Because cysteine has not been identi-
ﬁed as a catalytic residue in any DNA polymerase, we
presume that NEM inhibits pol g by interfering with the
formation of a ternary complex among the enzyme, the
primer template, and the incoming dinucleotide tri-
phosphate substrate. Association of p55 with p140 pro-
tects the catalytic subunit from inactivation by NEM,3,
22 and this protective effect has been used as a chemical
probe to assess association of the pol g subunits.19 In-
hibition of pol g at different concentrations of NEM
was reestablished in the standard polymerase assay, in
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Figure 6 G451E p55 fails to coimmunoprecipitate with p140.
The p140-dependent coimmunoprecipitation of WT p55 or G451E
p55 with immobilized anti-p140 rabbit antibodies was assayed as de-
scribed in the “Subjects and Methods” section. Samples containedWT
p55 alone (lane 1), p140 catalytic subunit andWT p55 (lane 2), G451E
mutant p55 (lane 3), p140 and G451E mutant p55 (lane 4), or 0.2 mg
each of p140 and p55 loaded directly as positive controls for the
western blot (lane 5). The positions of p140 and p55 standards are
indicated with arrows.
which 1.0 mM NEM inhibited the polymerase activity
of isolated p140 by ∼95% (ﬁg. 5). Brief preincubation
of p140 with a twofold molar excess of WT p55 pro-
tected 180% of polymerase activity at all concentrations
of NEM that were tested. A reduced level of protection
was observed on preincubation with the mutant form
of p55, and protection by G451E p55 was only 65%–
80% as effective as protection by WT p55 at NEM con-
centrations 10.1 mM. This intermediate protection of
p140 against attack by NEM further supports the notion
that the G451E substitution in p55 compromises asso-
ciation with the p140 subunit.
Impaired Subunit Interaction Revealed by Failure
to Immunoprecipitate G451E Subunit
Physical association of the subunits was evaluated fur-
ther by immunoprecipitation assay. Protein G Sepharose
beads were loaded with polyclonal antibodies raised
against puriﬁed recombinant p140, were washed thor-
oughly, and were used to test the ability of immobilized
p140 to capture the WT and mutant forms of p55.
Coimmunoprecipitation of WT p55 with p140 was
straightforward, and capture of p55 was clearly depen-
dent on the presence of p140 (ﬁg. 6, lanes 1 and 2).
However, p140 was unable to capture an appreciable
quantity of G451E p55 (ﬁg. 6, lanes 3 and 4). In separate
control experiments, increasing available G451E p55 to
5 mg and increasing the amount of beads by 250% did
not permit detection of G451E p55 in the immunopre-
cipitates (data not shown). Failure to coimmunoprecip-
itate G451E p55 further suggests a weakened interaction
between the G451E form of p55 and the p140 subunit.
G451E p55 Fails to Enhance the Processivity of p140
On binding productively to primer-template DNA, the
pol g catalytic subunit exhibits moderate processivity
by synthesizing 50–75 nt before dissociating from the
DNA.17 Association of the WT accessory subunit pro-
motes tighter binding to DNA (ﬁg. 4), and reduced dis-
sociation from the primer template signiﬁcantly in-
creases the processivity of the pol g complex to several
thousand nucleotides.3 Because processivity is a sensitive
functional assessment of subunit interaction during
DNA synthesis, the effects of G451E p55 on the pro-
cessivity of p140 were measured in gel-based primer ex-
tension assays (ﬁg. 7). Under reaction conditions that
limit DNA-binding events, the isolated p140 subunit ex-
tended the primer by 75–100 nt at 0 mM NaCl (ﬁg. 7A,
lane 1), and distinct pausing due to template secondary
structure at ∼50 and ∼85 nt was apparent, as observed
elsewhere.17–19 Primer extension activity of p140 was in-
hibited at 150 mM NaCl (ﬁg. 7A, lane 2). Inclusion of
WT p55 permitted primers to be extended by ∼150 nt
at low salt concentrations (ﬁg. 7A, lane 3). The addition
of 150 mM NaCl greatly reduced polymerase stalling
near the primer, and roughly half the products became
too large to enter the polyacrylamide gel (ﬁg. 7A, lane
4). In contrast, G451E p55 was unable to stimulate
primer extension by p140 at either salt concentration
(compare ﬁg. 7A lanes 1 and 2 with lanes 5 and 6).
Whereas physiological salt conditions are optimal for
activity of the p140-WT p55 complex,3 150 mM NaCl
may be high enough to mask stimulation of p140 by
G451E p55. However, when the experiment was re-
peated at 75 mM NaCl, no stimulatory effect was ob-
served for G451E p55 (data not shown). Similarly, in-
clusion of a DNA trap in the reactions to absolutely
restrict pol g to a single DNA-binding event did not
change our interpretation. Reaction products were also
separated on alkaline agarose gels to more fully resolve
the high–molecular-weight reaction products (ﬁg. 7B).
Again, isolated p140 was more active at low salt con-
centrations, and the shorter products were not well re-
solved by this method (ﬁg. 7B, lanes 1 and 2). When in
complex with WT p55, p140 synthesized products as
long as 7 kb or the full length of the M13 template (ﬁg.
7B, lanes 3 and 4). The absence of high–molecular-
weight primer extension products again demonstrates
the failure of G451E p55 to enhance the processivity of
p140 (ﬁg. 7B, lanes 5 and 6).
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Figure 7 G451E p55 does not enhance processive DNA syn-
thesis of pol g. Primer-extension reactions were performed as described
in the “Subjects and Methods” section. Reactions contained p140 cat-
alytic subunit (lanes 1–6), WT p55 (lanes 3 and 4), G451E p55 (lanes
5 and 6), and singly primed M13 DNA. Activity was measured at 0
mM NaCl (odd-numbered lanes) or 150 mM NaCl (even-numbered
lanes). Lane 0 had no enzyme. Reaction products were resolved by
denaturing polyacrylamide gel electrophoresis (A) and alkaline agarose
gel electrophoresis (B). The arrows in panels A and B mark the unex-
tended 35-mer primer. Markers indicate the number of nucleotides
synthesized past the primer.
The dominant inheritance pattern suggests that
G451E p55 may interfere with the natural function of
WT p55 in vivo. To investigate this possibility, we un-
dertook primer-extension assays to search for a domi-
nant negative biochemical effect in vitro. Consistentwith
recent work indicating that the pol g holoenzyme may
function as a heterotrimer,23,24 reactions were made to
contain two p55 subunits for every p140 subunit, and
the processivity of DNA synthesis was monitored as the
ratio of WT p55 to G451E p55 was varied. Over a wide
range of salt concentrations, the presence of G451E p55
did not diminish the stimulatory effects of WT p55 be-
yond that expected from simple dilution (data not
shown). In separate experiments, increasing amounts of
G451E p55 were titrated into standard reactions to test
for inhibition of processive DNA synthesis catalyzed by
p140-WT p55. An eightfold stoichiometric excess of
G451E p55 had no effect on p140-WT p55 activity,
suggesting that exchange of p55 subunits within the het-
erotrimer was not occurring in the 30-min time frame
of the experiment. Although the WT component of p55
dimers within the mitochondria of an individual hetero-
zygous for POLG2 cannot easily be determined, the fail-
ure of our mixing experiments to reveal a dominant
negative effect in vitro suggests that the phenotype of
the affected heterozygote may be due to simple hap-
loinsufﬁciency, as discussed below.
Discussion
This work describes the ﬁrst example, to our knowledge,
of a pathogenic mutation in POLG2. Clinically, the pa-
tient had typical late-onset PEO, with no speciﬁc clinical
features that were different from the other 100 patients
who were screened for POLG2 mutations and had a
WT sequence. One goal of this study was to identify
biochemical defects in the G451E p55 that might help
to explain the phenotypic changes caused by the G451E
substitution in vivo. Biochemical characterization of the
puriﬁed, recombinant G451E p55 protein in vitro re-
vealed incomplete stimulation of the catalytic subunit
and limited restoration of salt-tolerant polymerase ac-
tivity, as compared with the effects ofWT p55. Although
G451E p55 retains a WT ability to bind DNA, it fails
to enhance the DNA-binding strength of the p140-p55
complex. A weakened subunit interaction between
G451E p55 and p140 was further demonstrated by in-
termediate protection of p140 from inactivation with
NEM, by the failure of G451E p55 to coimmunopre-
cipitate with p140, and by the inability of G451E p55
to enhance the processivity of p140. Elsewhere, we char-
acterized a mutant form of the pol g catalytic subunit
associated with Alpers syndrome, juvenile spinocerebel-
lar ataxia-epilepsy syndrome, and recessive forms of
PEO, and this pathogenic A467T substitution both
caused a severe catalytic defect and interfered with as-
sociation of the subunits.19 Since the G451E substitution
in p55 disrupts only association of the subunits, we pro-
pose that any mutation that impairs assembly of the pol
g holoenzyme is sufﬁcient to stall the mtDNA replication
fork, thereby inducing mtDNA deletions and the atten-
dant disease phenotypes. Additionally, the G451E mu-
tation in POLG2 and pathogenic mutations in POLG
offer a unique opportunity to deﬁne the p140-p55 sub-
unit interface.
The proband in the current study is heterozygous for
the G451E substitution in p55, prompting the simple as-
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Figure 8 Homologous position of the G451E side chain on the
ribbon structure of the homodimeric mouse accessory subunit. The
ribbon drawing was generated with Swiss PDB viewer from Protein
Data Bank ﬁle 1G5H.23 Each monomer is colored either blue or red.
Amino acids in domains 1 and 2 constitute the dimer interfaces, which
are far removed from the homologous position of the G451E substi-
tution in human PEO (arrows). Helices A–M are explained in the
“Discussion” section.
sumption that haplotype insufﬁciency of POLG2 causes
disease by reducing the availability of functional pol g
holoenzyme. Such a partial loss of holoenzyme function
is consistent with the delayed onset of symptoms (at age
40 years) in the proband. In an extreme example of hap-
lotype insufﬁciency that affects the bioavailability of pol
g, we recently documented a similar gene-dose effect for
the pol g holoenzyme in which homozygous patients with
two A467T POLG alleles usually present with late-onset
Alpers syndrome or early ataxia in their teens, whereas
monoallelic expression of an A467T POLG allele was
accompanied by very early onset of Alpers syndrome.25
In contrast, evidence that the mother was similarly af-
fected suggests autosomal dominant inheritance of PEO
due to the G451E mutation in POLG2. In this situation,
the presence of the mutant G451E p55 should be able to
interfere with the normal functions of WT pol g holo-
enzyme. A dominant negative effect was not revealed by
mixing experiments in vitro, which supports the notion
that symptoms in affected heterozygotes are caused by
haplotype insufﬁciency.
A more complex analysis involving physical and struc-
tural studies of pol g also merits consideration. The crys-
tal structure of the mouse pol g accessory subunit in-
dicates that the isolated accessory subunit exists as a
homodimer23 (ﬁg. 8). The structure shows that each
monomer has three distinct domains, where domain 1
consists of a seven-stranded b-sheet and all strands ex-
cept one are antiparallel. One face of the twisted b-sheet
is covered with helices G and C, whereas the other sol-
vent-accessible b-sheet forms a pocket lined with helices
F and H. Domain 2 encompasses secondary structural
elements that interact with their symmetric counterparts
in the other monomer.23 Within this domain, three
strands from each monomer form a six-stranded anti-
parallel b-sheet across the dimer interface. Helices D and
E of each monomer form a four-helix bundle across the
homodimer interface, and the helical axes are roughly
parallel to the twofold axis relating both monomers.
Domain 3 contains a ﬁve-stranded mixed b-sheet located
between helices J and M on one side and a b-hairpin
(formed by two other strands) and helix K on the other
side. On the basis of the crystal structure of the mouse
p55, Gly451 in the human protein is located on the inner
face of domain 3 and is not involved in homodimeri-
zation of the accessory subunit (ﬁg. 8). Accordingly, the
G451E substitution in human p55 is unlikely to prevent
heterodimerization of G451E p55 and WT p55. How-
ever, deletion of 30 residues near the C-terminus of p55
(deletion of amino acids 456–485) disturbs the inner face
of domain 3 and prevents interaction with p140 in elec-
trophoretic mobility shift assays,26 which suggests that
this portion of p55 constitutes part of the interface with
the catalytic subunit. Also, recent biochemical evidence
demonstrates that the human p55 homodimer associates
with the catalytic subunit to form a 1:2 heterotrimer
(p140:p55:p55).24 The dissociation constant for p55
homodimers is very low (!0.1 nM).24 This predicts that
G451E and WT p55 monomers did not exchange during
our in vitro mixing experiments, which prevented us
from measuring any dominant negative effect in vitro.
Although factors affecting assembly of the pol g holo-
enzyme after importation of the subunits into mito-
chondria are not well studied, in vivo heterodimerization
of G451E and WT p55 remains a distinct possibility. By
extension, only one fourth of the pol g heterotrimers in
individuals heterozygous for POLG2 would be WT,
which may compromise mtDNA replication even more
effectively than simple haplotype insufﬁciency.
In summary, we have described the ﬁrst pathogenic
mutation in POLG2 that causes a disorder of mtDNA
maintenance. The G451E mutation disrupts interaction
between the accessory subunit and the catalytic subunit,
ultimately causing the multiple deletions in the mtDNA
of this patient. We therefore believe that POLG2 should
be included when searching for nuclear genes with mu-
tations that cause disorders of mtDNA maintenance, es-
pecially when POLG, C10orf2, ANT1, TK, DGUOK,
and TP are determined to have WT sequences in affected
patients.
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